These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 796918

  • 1. Malignant disease in immunodeficient states in man.
    Penn I.
    Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
    [No Abstract] [Full Text] [Related]

  • 2. Another look at immunologic surveillance.
    Schwartz RS.
    N Engl J Med; 1975 Jul 24; 293(4):181-4. PubMed ID: 1094290
    [No Abstract] [Full Text] [Related]

  • 3. Cancer is a complication of severe immunosuppression.
    Penn I.
    Surg Gynecol Obstet; 1986 Jun 24; 162(6):603-10. PubMed ID: 3520906
    [Abstract] [Full Text] [Related]

  • 4. [Development of lymphoma and leukemia in patients receiving immunosuppressive drugs].
    Rupniewska ZM, Kurowska M.
    Pol Tyg Lek; 1980 Mar 17; 35(11):411-4. PubMed ID: 6992123
    [No Abstract] [Full Text] [Related]

  • 5. Depressed immunity and the development of cancer.
    Penn I.
    Clin Exp Immunol; 1981 Dec 17; 46(3):459-74. PubMed ID: 7039892
    [No Abstract] [Full Text] [Related]

  • 6. Immunodeficiency and the pathogenesis of lymphoma and leukemia.
    Louie S, Schwartz RS.
    Semin Hematol; 1978 Apr 17; 15(2):117-38. PubMed ID: 349695
    [No Abstract] [Full Text] [Related]

  • 7. The occurrence of malignant tumors in immunosuppressed states.
    Penn I.
    Prog Allergy; 1986 Apr 17; 37():259-300. PubMed ID: 3515352
    [No Abstract] [Full Text] [Related]

  • 8. Tumour development following immunosuppression.
    Allison AC.
    Proc R Soc Med; 1970 Oct 17; 63(10):1077-80. PubMed ID: 4320709
    [No Abstract] [Full Text] [Related]

  • 9. Immunosuppressive chemotherapy and malignancy.
    Schwartz RS.
    Transplant Proc; 1974 Dec 17; 6(4 Suppl 1):45-8. PubMed ID: 4612903
    [No Abstract] [Full Text] [Related]

  • 10. Malignancy as a complication of immunosuppressive therapy.
    Leibowitz S, Schwartz RS.
    Adv Intern Med; 1971 Dec 17; 17():95-123. PubMed ID: 4145004
    [No Abstract] [Full Text] [Related]

  • 11. CADAVERIC RENAL HOMOTRANSPLANTATION WITH INADVERTENT TRANSPLANTATION OF CARCINOMA.
    MARTIN DC, RUBINI M, ROSEN VJ.
    JAMA; 1965 May 31; 192():752-4. PubMed ID: 14285706
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppression, genesis and growth of malignant tumours].
    Reis HE.
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 May 31; 78(1):42-50. PubMed ID: 4264377
    [No Abstract] [Full Text] [Related]

  • 13. Editorial: Immune surveillance revisited.
    Kripke ML, Borsos T.
    J Natl Cancer Inst; 1974 May 31; 52(5):1393-5. PubMed ID: 4831431
    [No Abstract] [Full Text] [Related]

  • 14. Organ transplantation and cancer.
    Fortner JG, Shiu MH.
    Surg Clin North Am; 1974 Aug 31; 54(4):871-6. PubMed ID: 4610843
    [No Abstract] [Full Text] [Related]

  • 15. [Significance of immunosuppression for the origin and growth of malignant tumors].
    Reis HE.
    Dtsch Med Wochenschr; 1971 Jan 22; 96(4):170-4. PubMed ID: 4992740
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression and cancer.
    Penn I, Starzl TE.
    Transplant Proc; 1973 Mar 22; 5(1):943-7. PubMed ID: 4735211
    [No Abstract] [Full Text] [Related]

  • 17. [Malignant neoplasms after organ transplantation].
    Mol'kov IuN, Golikova SD, Balakirev EM.
    Vopr Onkol; 1980 Mar 22; 26(11):107-13. PubMed ID: 7006209
    [No Abstract] [Full Text] [Related]

  • 18. Malignancies in recipients of organ transplants.
    Penn I.
    Johns Hopkins Med J Suppl; 1974 Mar 22; 3():211-21. PubMed ID: 4608179
    [No Abstract] [Full Text] [Related]

  • 19. Occurrence of cancer in immune deficiencies.
    Penn I.
    Cancer; 1974 Sep 22; 34(3):suppl:858-66. PubMed ID: 4853422
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.